 NEW YORK and LONDON, Oct. 27, 2020 GLOBE NEWSWIRE -- Akari Therapeutics, Plc Nasdaq: AKTX, a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement andor leukotriene systems are implicated, today announces that it will be presenting a poster during the 29th European Academy of Dermatology and Venereology EADV Congress being held virtually October 28 November 1, 2020. The presentation will be posted onto Akaris website. 